• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

De-Escalation of Dual Antiplatelet Regimens in East Asian Patients Undergoing Coronary Intervention.

作者信息

Kim Moo Hyun, Choi Sun Young, Serebruany Victor

机构信息

Department of Cardiology, Dong-A University Hospital, Busan, South Korea.

Department of Biomedical Laboratory Science, Daegu Health College, Daegu, South Korea.

出版信息

Am J Ther. 2020 Nov/Dec;27(6):e611-e612. doi: 10.1097/MJT.0000000000001237.

DOI:10.1097/MJT.0000000000001237
PMID:33156017
Abstract
摘要

相似文献

1
De-Escalation of Dual Antiplatelet Regimens in East Asian Patients Undergoing Coronary Intervention.东亚接受冠状动脉介入治疗患者双联抗血小板治疗方案的降阶梯治疗
Am J Ther. 2020 Nov/Dec;27(6):e611-e612. doi: 10.1097/MJT.0000000000001237.
2
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.基于普拉格雷的急性冠状动脉综合征患者经皮冠状动脉介入治疗后双联抗血小板治疗降级（HOST-REDUCE-POLYTECH-ACS）：一项开放标签、多中心、非劣效性随机试验。
Lancet. 2020 Oct 10;396(10257):1079-1089. doi: 10.1016/S0140-6736(20)31791-8. Epub 2020 Aug 31.
3
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的抗血小板治疗降级指导（TROPICAL-ACS）：一项随机、开放标签、多中心试验。
Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.
4
Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial.指导急性冠状动脉综合征患者经皮冠状动脉介入治疗伴生物可吸收支架植入术后的 DAPT 降级：随机 TROPICAL-ACS 试验的事后分析。
J Thromb Thrombolysis. 2019 Apr;47(3):427-435. doi: 10.1007/s11239-019-01811-2.
5
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.急性冠状动脉综合征患者行经皮冠状动脉介入治疗后抗血小板治疗降级指导的年龄与结局：随机 TROPICAL-ACS 试验结果。
Eur Heart J. 2018 Aug 1;39(29):2749-2758. doi: 10.1093/eurheartj/ehy332.
6
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试（TROPICAL-ACS）试验的原理与设计。
Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.
7
De-Escalation of Dual Antiplatelet Therapy: Will We Ever Get to the Right Method?
J Cardiovasc Pharmacol. 2022 Aug 1;80(2):203-205. doi: 10.1097/FJC.0000000000001304.
8
Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.糖尿病患者行经皮冠状动脉介入治疗的急性冠状动脉综合征患者抗血小板治疗降级指导后的结局：来自随机 TROPICAL-ACS 试验的预先指定分析。
EuroIntervention. 2019 Aug 9;15(6):e513-e521. doi: 10.4244/EIJ-D-18-01077.
9
Prasugrel hydrochloride for the treatment of acute coronary syndrome patients.盐酸普拉格雷用于治疗急性冠脉综合征患者。
Expert Rev Cardiovasc Ther. 2016 Nov;14(11):1215-1226. doi: 10.1080/14779072.2016.1245145.
10
Prasugrel and ticagrelor compared to clopidogrel in non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary interventions: Certainties and uncertainties.在接受经皮冠状动脉介入治疗的非ST段抬高型急性冠状动脉综合征中，普拉格雷和替格瑞洛与氯吡格雷的比较：确定与不确定之处。
Int J Cardiol. 2015 Feb 15;181:443-5. doi: 10.1016/j.ijcard.2014.11.131. Epub 2014 Nov 25.

引用本文的文献

1
Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial.东亚急性冠状动脉综合征患者采用半量普拉格雷或替格瑞洛降阶梯治疗策略的药效学及结果：HOPE-TAILOR试验结果
J Clin Med. 2021 Jun 18;10(12):2699. doi: 10.3390/jcm10122699.